171 related articles for article (PubMed ID: 17367042)
21. Acitretin for the treatment of psoriasis: an assessment of national trends.
Ghasri P; Yentzer BA; Dabade TS; Feldman SR
J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
[TBL] [Abstract][Full Text] [Related]
22. [Guidelines for high-quality use of biologic therapies in adults with plaque psoriasis].
Marques Pinto G; Filipe P
Acta Med Port; 2012; 25(2):125-41. PubMed ID: 22985925
[TBL] [Abstract][Full Text] [Related]
23. Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
Price J; Bhosle M; Feldman SR; Balkrishnan R
J Drugs Dermatol; 2007 Mar; 6(3):259-67. PubMed ID: 17373187
[TBL] [Abstract][Full Text] [Related]
24. Compatibility of topical therapies for psoriasis: challenges and innovations.
Lebwohl MG; Corvari L
Cutis; 2007 Jan; 79(1 Suppl 2):5-10. PubMed ID: 17367040
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
26. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
Freeman K
Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
[TBL] [Abstract][Full Text] [Related]
27. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
[TBL] [Abstract][Full Text] [Related]
28. A clinician's paradigm in the treatment of psoriasis.
Lebwohl M
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S59-69. PubMed ID: 15968265
[TBL] [Abstract][Full Text] [Related]
29. Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
Saraceno R; Gramiccia T; Frascione P; Chimenti S
Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634
[TBL] [Abstract][Full Text] [Related]
30. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of 308nm laser treatment of psoriasis compared to historical controls.
Rodewald EJ; Housman TS; Mellen BG; Feldman SR
Dermatol Online J; 2001 Dec; 7(2):4. PubMed ID: 12165220
[TBL] [Abstract][Full Text] [Related]
32. Current effective topical therapies in the management of psoriasis.
Kurian A; Barankin B
Skin Therapy Lett; 2011 Jan; 16(1):4-7. PubMed ID: 21293834
[TBL] [Abstract][Full Text] [Related]
33. Childhood psoriasis.
Dogra S; Kaur I
Indian J Dermatol Venereol Leprol; 2010; 76(4):357-65. PubMed ID: 20657115
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
[TBL] [Abstract][Full Text] [Related]
35. Combining systemic retinoids with biologic agents for moderate to severe psoriasis.
Smith EC; Riddle C; Menter MA; Lebwohl M
Int J Dermatol; 2008 May; 47(5):514-8. PubMed ID: 18412874
[TBL] [Abstract][Full Text] [Related]
36. Scalp psoriasis: a review of current topical treatment options.
Papp K; Berth-Jones J; Kragballe K; Wozel G; de la Brassinne M
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1151-60. PubMed ID: 17894698
[TBL] [Abstract][Full Text] [Related]
37. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation.
Menon K; Van Voorhees AS; Bebo BF; Gladman DD; Hsu S; Kalb RE; Lebwohl MG; Strober BE;
J Am Acad Dermatol; 2010 Feb; 62(2):291-9. PubMed ID: 19646777
[TBL] [Abstract][Full Text] [Related]
38. Psoriasis: what is new in nonbiologic systemic therapy in the era of biologics?
Kanwar AJ; Yadav S; Dogra S
Indian J Dermatol Venereol Leprol; 2010; 76(6):622-33. PubMed ID: 21079305
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
40. Class I topical corticosteroid use by psoriasis patients in an academic practice.
Pearce DJ; Spencer L; Hu J; Balkrishnan R; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Jul; 15(4):235-8. PubMed ID: 15764038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
